The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.
For some people, the urge to eat is uncontrollable. Cambridge scientists have taken us a step closer to understanding the causes of obesity by studying a group of patients for whom overeating is an everyday event.